Same-Day Shipping
Trusted AU Source
Same Business Day Dispatch*
Local Stock
Shipped Discreetly
High Purity Premium Stock
CoA Every Batch
Shopping Cart
Your cart is currently empty.

Retatrutide 20mg

Retatrutide 20mg

Retatrutide 20mg is a high-purity research peptide supplied as a lyophilized powder in a sterile vial. Intended exclusively for laboratory and scientific research.

$220.00

15 in stock

Retatrutide Triple-Receptor Agonist for Metabolic Research

Retatrutide 20mg is supplied by Buy AUZ Peptide for controlled laboratory and in-vitro research applications in Australia, with domestic dispatch available to eligible purchasers across all states and territories.
Retatrutide is an investigational peptide studied for its activity across three metabolically relevant receptor systems: GLP-1, GIP and glucagon receptors. This triple-receptor activity distinguishes it from single- and dual-receptor compounds used in metabolic research.
The 20mg research format provides a higher quantity of material for laboratory studies requiring extended experimental designs, comparative analysis or consistent material from a single documented batch.

Key Research Areas

  • Triple-Receptor Signalling — Investigated for activity involving GLP-1, GIP and glucagon receptor pathways.
  • Metabolic Regulation Research — Studied in experimental research examining energy balance, nutrient signalling and metabolic regulatory mechanisms.
  • Glucose Metabolism Research — Investigated for its relationship with glucose regulation, insulin-associated pathways and metabolic responses.
  • Adipose Tissue Biology — Studied in research involving adipose tissue signalling, energy storage and related metabolic processes.
  • Appetite & Satiety Signalling — Investigated in research examining pathways associated with food-intake regulation, appetite and satiety.
  • Energy Expenditure Research — Its glucagon-receptor activity has generated research interest in pathways associated with energy utilisation and metabolic expenditure.
  • Comparative Incretin Research — Retatrutide can be studied alongside other incretin-related compounds to investigate differences between single-, dual- and triple-receptor signalling systems.

Retatrutide 20mg is supplied as a lyophilised research material, with a batch-specific purity of 99.867% as reported on the current Certificate of Analysis.
Where documented for the applicable batch, analytical verification may include HPLC and mass spectrometry. Researchers should review the current batch-specific CoA for exact purity, compound identification and analytical results before laboratory use.
Buy AUZ Peptide provides Australian researchers with access to clear technical specifications, available batch documentation and domestic product fulfilment.
For in-vitro research and laboratory use only. Not intended for human or veterinary use, consumption, diagnosis, treatment or therapeutic application.

Specification Details
Compound Retatrutide
Strength 20mg
CAS Number 2381089-83-2
Category Metabolic Research
Research Profile GLP-1 / GIP / Glucagon Receptor Agonist
Purity 99.867% (CoA Reported)
Form Lyophilised Powder
Testing HPLC / Mass Spectrometry [confirm against current CoA]
Storage – Lyophilised -20°C — protect from light and moisture
Storage After Preparation [ADD CLIENT-APPROVED STORAGE INFORMATION]
Certificate of Analysis Batch-specific CoA available
Supply Location Australia
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.

Top Research Peptides

Best Sellers

Frequently Asked Questions

faq